Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Long-Term Investments: 2018-2025

Historic Long-Term Investments for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $122.0 million.

  • Dr Reddys Laboratories' Long-Term Investments rose 144.00% to $122.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $122.0 million, marking a year-over-year increase of 144.00%. This contributed to the annual value of $122.0 million for FY2025, which is 144.00% up from last year.
  • According to the latest figures from FY2025, Dr Reddys Laboratories' Long-Term Investments is $122.0 million, which was up 144.00% from $50.0 million recorded in FY2024.
  • Dr Reddys Laboratories' 5-year Long-Term Investments high stood at $122.0 million for FY2025, and its period low was $50.0 million during FY2024.
  • Moreover, its 3-year median value for Long-Term Investments was $57.0 million (2023), whereas its average is $76.3 million.
  • As far as peak fluctuations go, Dr Reddys Laboratories' Long-Term Investments fell by 16.18% in 2022, and later soared by 144.00% in 2025.
  • Dr Reddys Laboratories' Long-Term Investments (Yearly) stood at $68.0 million in 2021, then dropped by 16.18% to $57.0 million in 2022, then remained steady at $57.0 million in 2023, then dropped by 12.28% to $50.0 million in 2024, then surged by 144.00% to $122.0 million in 2025.